サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1762998

IV用溶液の世界市場 2025年～2029年

Global Intravenous (IV) Solutions Market 2025-2029

出版日
発行
TechNavio
ページ情報
英文 209 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.02円
IV用溶液の世界市場 2025年～2029年
出版日: 2025年06月25日
発行: TechNavio
ページ情報: 英文 209 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

IV用溶液市場は2024年～2029年に56億4,920万米ドル、予測期間中のCAGRは8.5%で成長すると予測されます。

当レポートでは、IV用溶液市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、慢性疾患の有病率の増加、老人人口の増加、非経口栄養に対する需要の増加によって牽引されています。

市場範囲
基準年 2025年
終了年 2029年
予測期間 2025年～2029年
成長モメンタム 加速
前年比 7.7%
CAGR 8.5%
増分額 56億4,920万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間のIV用溶液市場の成長を促進する主な理由の一つとして、IVソリューションの技術的進歩を挙げています。また、在宅ヘルスケアの需要増加やヘルスケア分野への投資拡大も市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2024年
  • 市場の見通し 2024年～2029年

第5章 市場規模実績

  • IV用溶液の世界市場 2019年～2023年
  • タイプ別セグメント分析 2019年～2023年
  • 流通チャネル別セグメント分析 2019年～2023年
  • 製剤別セグメント分析 2019年～2023年
  • 地域別セグメント分析 2019年～2023年
  • 国別セグメント分析 2019年～2023年

第6章 定性分析

  • AIの影響：IV用溶液の世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：タイプ別

  • 市場セグメント
  • 比較：タイプ別
  • 部分的静脈栄養：市場規模と予測 2024年～2029年
  • 完全静脈栄養：市場規模と予測 2024年～2029年
  • 市場機会：タイプ別

第9章 市場セグメンテーション：流通チャネル別

  • 市場セグメント
  • 比較：流通チャネル別
  • 病院薬局：市場規模と予測 2024年～2029年
  • 小売薬局：市場規模と予測 2024年～2029年
  • オンライン薬局：市場規模と予測 2024年～2029年
  • 市場機会：流通チャネル別

第10章 市場セグメンテーション：製剤別

  • 市場セグメント
  • 比較：製剤別
  • 炭水化物：市場規模と予測 2024年～2029年
  • 電解質とミネラル：市場規模と予測 2024年～2029年
  • アミノ酸：市場規模と予測 2024年～2029年
  • ビタミンと脂質：市場規模と予測 2024年～2029年
  • 市場機会：製剤別

第11章 顧客情勢

  • 顧客情勢の概要

第12章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • アジア：市場規模と予測 2024年～2029年
  • 北米：市場規模と予測 2024年～2029年
  • 欧州：市場規模と予測 2024年～2029年
  • 世界のその他の地域：市場規模と予測 2024年～2029年
  • 米国：市場規模と予測 2024年～2029年
  • 中国：市場規模と予測 2024年～2029年
  • ドイツ：市場規模と予測 2024年～2029年
  • インド：市場規模と予測 2024年～2029年
  • 英国：市場規模と予測 2024年～2029年
  • 日本：市場規模と予測 2024年～2029年
  • ブラジル：市場規模と予測 2024年～2029年
  • カナダ：市場規模と予測 2024年～2029年
  • フランス：市場規模と予測 2024年～2029年
  • 韓国：市場規模と予測 2024年～2029年
  • 市場機会：地域情勢別

第13章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第14章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第15章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • Amanta Healthcare Ltd.
  • Axa Parenterals Ltd.
  • B.Braun SE
  • Baxter International Inc.
  • Fresenius SE and Co. KGaA
  • Grifols SA
  • ICU Medical Inc.
  • JW Pharmaceutical Corp.
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Salius Pharma Pvt. Ltd.
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Soxa Formulations and Research Pvt. Ltd.
  • Terumo Corp.
  • Vifor Pharma Management Ltd.

第16章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits7: Executive Summary - Chart on Market Segmentation by Formulation
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global Intravenous (IV) Solutions Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - Formulation Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Type - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Type - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Type
  • Exhibits41: Data Table on Comparison by Type
  • Exhibits42: Chart on Partial parenteral nutrition - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on Partial parenteral nutrition - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on Partial parenteral nutrition - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on Partial parenteral nutrition - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Total parenteral nutrition - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Total parenteral nutrition - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Total parenteral nutrition - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Total parenteral nutrition - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Market opportunity by Type ($ million)
  • Exhibits51: Data Table on Market opportunity by Type ($ million)
  • Exhibits52: Chart on Distribution Channel - Market share 2024-2029 (%)
  • Exhibits53: Data Table on Distribution Channel - Market share 2024-2029 (%)
  • Exhibits54: Chart on Comparison by Distribution Channel
  • Exhibits55: Data Table on Comparison by Distribution Channel
  • Exhibits56: Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits57: Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits58: Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits59: Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits60: Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits61: Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits62: Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits63: Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits64: Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits65: Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits66: Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits67: Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits68: Market opportunity by Distribution Channel ($ million)
  • Exhibits69: Data Table on Market opportunity by Distribution Channel ($ million)
  • Exhibits70: Chart on Formulation - Market share 2024-2029 (%)
  • Exhibits71: Data Table on Formulation - Market share 2024-2029 (%)
  • Exhibits72: Chart on Comparison by Formulation
  • Exhibits73: Data Table on Comparison by Formulation
  • Exhibits74: Chart on Carbohydrates - Market size and forecast 2024-2029 ($ million)
  • Exhibits75: Data Table on Carbohydrates - Market size and forecast 2024-2029 ($ million)
  • Exhibits76: Chart on Carbohydrates - Year-over-year growth 2024-2029 (%)
  • Exhibits77: Data Table on Carbohydrates - Year-over-year growth 2024-2029 (%)
  • Exhibits78: Chart on Electrolytes and minerals - Market size and forecast 2024-2029 ($ million)
  • Exhibits79: Data Table on Electrolytes and minerals - Market size and forecast 2024-2029 ($ million)
  • Exhibits80: Chart on Electrolytes and minerals - Year-over-year growth 2024-2029 (%)
  • Exhibits81: Data Table on Electrolytes and minerals - Year-over-year growth 2024-2029 (%)
  • Exhibits82: Chart on Amino acids - Market size and forecast 2024-2029 ($ million)
  • Exhibits83: Data Table on Amino acids - Market size and forecast 2024-2029 ($ million)
  • Exhibits84: Chart on Amino acids - Year-over-year growth 2024-2029 (%)
  • Exhibits85: Data Table on Amino acids - Year-over-year growth 2024-2029 (%)
  • Exhibits86: Chart on Vitamins and lipids - Market size and forecast 2024-2029 ($ million)
  • Exhibits87: Data Table on Vitamins and lipids - Market size and forecast 2024-2029 ($ million)
  • Exhibits88: Chart on Vitamins and lipids - Year-over-year growth 2024-2029 (%)
  • Exhibits89: Data Table on Vitamins and lipids - Year-over-year growth 2024-2029 (%)
  • Exhibits90: Market opportunity by Formulation ($ million)
  • Exhibits91: Data Table on Market opportunity by Formulation ($ million)
  • Exhibits92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits93: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits94: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits95: Chart on Geographic comparison
  • Exhibits96: Data Table on Geographic comparison
  • Exhibits97: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits98: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits99: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits100: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits101: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits102: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits103: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits104: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits105: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits106: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits107: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits108: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits109: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Market opportunity By Geographical Landscape ($ million)
  • Exhibits154: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits155: Impact of drivers and challenges in 2024 and 2029
  • Exhibits156: Overview on criticality of inputs and factors of differentiation
  • Exhibits157: Overview on factors of disruption
  • Exhibits158: Impact of key risks on business
  • Exhibits159: Companies covered
  • Exhibits160: Company ranking index
  • Exhibits161: Matrix on companies position and classification
  • Exhibits162: Amanta Healthcare Ltd. - Overview
  • Exhibits163: Amanta Healthcare Ltd. - Product / Service
  • Exhibits164: Amanta Healthcare Ltd. - Key offerings
  • Exhibits165: SWOT
  • Exhibits166: Axa Parenterals Ltd. - Overview
  • Exhibits167: Axa Parenterals Ltd. - Product / Service
  • Exhibits168: Axa Parenterals Ltd. - Key offerings
  • Exhibits169: SWOT
  • Exhibits170: B.Braun SE - Overview
  • Exhibits171: B.Braun SE - Product / Service
  • Exhibits172: B.Braun SE - Key news
  • Exhibits173: B.Braun SE - Key offerings
  • Exhibits174: SWOT
  • Exhibits175: Baxter International Inc. - Overview
  • Exhibits176: Baxter International Inc. - Business segments
  • Exhibits177: Baxter International Inc. - Key news
  • Exhibits178: Baxter International Inc. - Key offerings
  • Exhibits179: Baxter International Inc. - Segment focus
  • Exhibits180: SWOT
  • Exhibits181: Fresenius SE and Co. KGaA - Overview
  • Exhibits182: Fresenius SE and Co. KGaA - Business segments
  • Exhibits183: Fresenius SE and Co. KGaA - Key news
  • Exhibits184: Fresenius SE and Co. KGaA - Key offerings
  • Exhibits185: Fresenius SE and Co. KGaA - Segment focus
  • Exhibits186: SWOT
  • Exhibits187: Grifols SA - Overview
  • Exhibits188: Grifols SA - Business segments
  • Exhibits189: Grifols SA - Key news
  • Exhibits190: Grifols SA - Key offerings
  • Exhibits191: Grifols SA - Segment focus
  • Exhibits192: SWOT
  • Exhibits193: ICU Medical Inc. - Overview
  • Exhibits194: ICU Medical Inc. - Product / Service
  • Exhibits195: ICU Medical Inc. - Key offerings
  • Exhibits196: SWOT
  • Exhibits197: JW Pharmaceutical Corp. - Overview
  • Exhibits198: JW Pharmaceutical Corp. - Product / Service
  • Exhibits199: JW Pharmaceutical Corp. - Key offerings
  • Exhibits200: SWOT
  • Exhibits201: Otsuka Holdings Co. Ltd. - Overview
  • Exhibits202: Otsuka Holdings Co. Ltd. - Business segments
  • Exhibits203: Otsuka Holdings Co. Ltd. - Key news
  • Exhibits204: Otsuka Holdings Co. Ltd. - Key offerings
  • Exhibits205: Otsuka Holdings Co. Ltd. - Segment focus
  • Exhibits206: SWOT
  • Exhibits207: Pfizer Inc. - Overview
  • Exhibits208: Pfizer Inc. - Product / Service
  • Exhibits209: Pfizer Inc. - Key news
  • Exhibits210: Pfizer Inc. - Key offerings
  • Exhibits211: SWOT
  • Exhibits212: Salius Pharma Pvt. Ltd. - Overview
  • Exhibits213: Salius Pharma Pvt. Ltd. - Product / Service
  • Exhibits214: Salius Pharma Pvt. Ltd. - Key offerings
  • Exhibits215: SWOT
  • Exhibits216: Sichuan Kelun Pharmaceutical Co. Ltd. - Overview
  • Exhibits217: Sichuan Kelun Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits218: Sichuan Kelun Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits219: SWOT
  • Exhibits220: Soxa Formulations and Research Pvt. Ltd. - Overview
  • Exhibits221: Soxa Formulations and Research Pvt. Ltd. - Product / Service
  • Exhibits222: Soxa Formulations and Research Pvt. Ltd. - Key offerings
  • Exhibits223: SWOT
  • Exhibits224: Terumo Corp. - Overview
  • Exhibits225: Terumo Corp. - Business segments
  • Exhibits226: Terumo Corp. - Key news
  • Exhibits227: Terumo Corp. - Key offerings
  • Exhibits228: Terumo Corp. - Segment focus
  • Exhibits229: SWOT
  • Exhibits230: Vifor Pharma Management Ltd. - Overview
  • Exhibits231: Vifor Pharma Management Ltd. - Product / Service
  • Exhibits232: Vifor Pharma Management Ltd. - Key offerings
  • Exhibits233: SWOT
  • Exhibits234: Inclusions checklist
  • Exhibits235: Exclusions checklist
  • Exhibits236: Currency conversion rates for US$
  • Exhibits237: Research methodology
  • Exhibits238: Information sources
  • Exhibits239: Data validation
  • Exhibits240: Validation techniques employed for market sizing
  • Exhibits241: Data synthesis
  • Exhibits242: 360 degree market analysis
  • Exhibits243: List of abbreviations
目次
Product Code: IRTNTR75229

The intravenous (IV) solutions market is forecasted to grow by USD 5,649.2 mn during 2024-2029, accelerating at a CAGR of 8.5% during the forecast period. The report on the intravenous (IV) solutions market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, growing geriatric population, and increasing demand for parenteral nutrition.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20257.7%
CAGR8.5%
Incremental Value$5,649.2 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's intravenous (IV) solutions market is segmented as below:

By Type

    • Partial parenteral nutrition
    • Total parenteral nutrition

By Distribution Channel

    • Hospital pharmacy
    • Retail pharmacy
    • Online pharmacy

By Formulation

    • Carbohydrates
    • Electrolytes and minerals
    • Amino acids
    • Vitamins and lipids

By Geographical Landscape

    • Asia
    • North America
    • Europe
    • Rest of World (ROW)

This study identifies the technological advancements in iv solutions as one of the prime reasons driving the intravenous (IV) solutions market growth during the next few years. Also, increasing demand for home healthcare and growing investments in healthcare sector will lead to sizable demand in the market.

The report on the intravenous (IV) solutions market covers the following areas:

    • Intravenous (IV) Solutions Market sizing
    • Intravenous (IV) Solutions Market forecast
    • Intravenous (IV) Solutions Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading intravenous (IV) solutions market vendors that include Amanta Healthcare Ltd., Axa Parenterals Ltd., B.Braun SE, Baxter International Inc., Fresenius SE and Co. KGaA, Grifols SA, ICU Medical Inc., JW Pharmaceutical Corp., Lxir Medilabs Pvt. Ltd., MITS Healthcare Pvt. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., Salius Pharma Pvt. Ltd., Schwitz Biotech, Sichuan Kelun Pharmaceutical Co. Ltd., Soxa Formulations and Research Pvt. Ltd., Terumo Corp., Vifor Pharma Management Ltd., Vikrant Life Sciences Pvt. Ltd., and Vitapure Corp.. Also, the intravenous (IV) solutions market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by Distribution Channel
    • Executive Summary - Chart on Market Segmentation by Formulation
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Intravenous (IV) Solutions Market 2019 - 2023
    • Historic Market Size - Data Table on Global Intravenous (IV) Solutions Market 2019 - 2023 ($ million)
  • 5.2 Type segment analysis 2019 - 2023
    • Historic Market Size - Type Segment 2019 - 2023 ($ million)
  • 5.3 Distribution Channel segment analysis 2019 - 2023
    • Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
  • 5.4 Formulation segment analysis 2019 - 2023
    • Historic Market Size - Formulation Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI in global intravenous (IV) solutions market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Type

  • 8.1 Market segments
    • Chart on Type - Market share 2024-2029 (%)
    • Data Table on Type - Market share 2024-2029 (%)
  • 8.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 8.3 Partial parenteral nutrition - Market size and forecast 2024-2029
    • Chart on Partial parenteral nutrition - Market size and forecast 2024-2029 ($ million)
    • Data Table on Partial parenteral nutrition - Market size and forecast 2024-2029 ($ million)
    • Chart on Partial parenteral nutrition - Year-over-year growth 2024-2029 (%)
    • Data Table on Partial parenteral nutrition - Year-over-year growth 2024-2029 (%)
  • 8.4 Total parenteral nutrition - Market size and forecast 2024-2029
    • Chart on Total parenteral nutrition - Market size and forecast 2024-2029 ($ million)
    • Data Table on Total parenteral nutrition - Market size and forecast 2024-2029 ($ million)
    • Chart on Total parenteral nutrition - Year-over-year growth 2024-2029 (%)
    • Data Table on Total parenteral nutrition - Year-over-year growth 2024-2029 (%)
  • 8.5 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Distribution Channel

  • 9.1 Market segments
    • Chart on Distribution Channel - Market share 2024-2029 (%)
    • Data Table on Distribution Channel - Market share 2024-2029 (%)
  • 9.2 Comparison by Distribution Channel
    • Chart on Comparison by Distribution Channel
    • Data Table on Comparison by Distribution Channel
  • 9.3 Hospital pharmacy - Market size and forecast 2024-2029
    • Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
    • Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • 9.4 Retail pharmacy - Market size and forecast 2024-2029
    • Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
    • Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
    • Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • 9.5 Online pharmacy - Market size and forecast 2024-2029
    • Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
    • Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
    • Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
  • 9.6 Market opportunity by Distribution Channel
    • Market opportunity by Distribution Channel ($ million)
    • Data Table on Market opportunity by Distribution Channel ($ million)

10 Market Segmentation by Formulation

  • 10.1 Market segments
    • Chart on Formulation - Market share 2024-2029 (%)
    • Data Table on Formulation - Market share 2024-2029 (%)
  • 10.2 Comparison by Formulation
    • Chart on Comparison by Formulation
    • Data Table on Comparison by Formulation
  • 10.3 Carbohydrates - Market size and forecast 2024-2029
    • Chart on Carbohydrates - Market size and forecast 2024-2029 ($ million)
    • Data Table on Carbohydrates - Market size and forecast 2024-2029 ($ million)
    • Chart on Carbohydrates - Year-over-year growth 2024-2029 (%)
    • Data Table on Carbohydrates - Year-over-year growth 2024-2029 (%)
  • 10.4 Electrolytes and minerals - Market size and forecast 2024-2029
    • Chart on Electrolytes and minerals - Market size and forecast 2024-2029 ($ million)
    • Data Table on Electrolytes and minerals - Market size and forecast 2024-2029 ($ million)
    • Chart on Electrolytes and minerals - Year-over-year growth 2024-2029 (%)
    • Data Table on Electrolytes and minerals - Year-over-year growth 2024-2029 (%)
  • 10.5 Amino acids - Market size and forecast 2024-2029
    • Chart on Amino acids - Market size and forecast 2024-2029 ($ million)
    • Data Table on Amino acids - Market size and forecast 2024-2029 ($ million)
    • Chart on Amino acids - Year-over-year growth 2024-2029 (%)
    • Data Table on Amino acids - Year-over-year growth 2024-2029 (%)
  • 10.6 Vitamins and lipids - Market size and forecast 2024-2029
    • Chart on Vitamins and lipids - Market size and forecast 2024-2029 ($ million)
    • Data Table on Vitamins and lipids - Market size and forecast 2024-2029 ($ million)
    • Chart on Vitamins and lipids - Year-over-year growth 2024-2029 (%)
    • Data Table on Vitamins and lipids - Year-over-year growth 2024-2029 (%)
  • 10.7 Market opportunity by Formulation
    • Market opportunity by Formulation ($ million)
    • Data Table on Market opportunity by Formulation ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.4 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.5 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.9 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.10 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.11 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.12 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.13 Brazil - Market size and forecast 2024-2029
    • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
    • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
    • Chart on Brazil - Year-over-year growth 2024-2029 (%)
    • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • 12.14 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.15 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.16 South Korea - Market size and forecast 2024-2029
    • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
    • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
    • Chart on South Korea - Year-over-year growth 2024-2029 (%)
    • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Amanta Healthcare Ltd.
    • Amanta Healthcare Ltd. - Overview
    • Amanta Healthcare Ltd. - Product / Service
    • Amanta Healthcare Ltd. - Key offerings
    • SWOT
  • 15.5 Axa Parenterals Ltd.
    • Axa Parenterals Ltd. - Overview
    • Axa Parenterals Ltd. - Product / Service
    • Axa Parenterals Ltd. - Key offerings
    • SWOT
  • 15.6 B.Braun SE
    • B.Braun SE - Overview
    • B.Braun SE - Product / Service
    • B.Braun SE - Key news
    • B.Braun SE - Key offerings
    • SWOT
  • 15.7 Baxter International Inc.
    • Baxter International Inc. - Overview
    • Baxter International Inc. - Business segments
    • Baxter International Inc. - Key news
    • Baxter International Inc. - Key offerings
    • Baxter International Inc. - Segment focus
    • SWOT
  • 15.8 Fresenius SE and Co. KGaA
    • Fresenius SE and Co. KGaA - Overview
    • Fresenius SE and Co. KGaA - Business segments
    • Fresenius SE and Co. KGaA - Key news
    • Fresenius SE and Co. KGaA - Key offerings
    • Fresenius SE and Co. KGaA - Segment focus
    • SWOT
  • 15.9 Grifols SA
    • Grifols SA - Overview
    • Grifols SA - Business segments
    • Grifols SA - Key news
    • Grifols SA - Key offerings
    • Grifols SA - Segment focus
    • SWOT
  • 15.10 ICU Medical Inc.
    • ICU Medical Inc. - Overview
    • ICU Medical Inc. - Product / Service
    • ICU Medical Inc. - Key offerings
    • SWOT
  • 15.11 JW Pharmaceutical Corp.
    • JW Pharmaceutical Corp. - Overview
    • JW Pharmaceutical Corp. - Product / Service
    • JW Pharmaceutical Corp. - Key offerings
    • SWOT
  • 15.12 Otsuka Holdings Co. Ltd.
    • Otsuka Holdings Co. Ltd. - Overview
    • Otsuka Holdings Co. Ltd. - Business segments
    • Otsuka Holdings Co. Ltd. - Key news
    • Otsuka Holdings Co. Ltd. - Key offerings
    • Otsuka Holdings Co. Ltd. - Segment focus
    • SWOT
  • 15.13 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 15.14 Salius Pharma Pvt. Ltd.
    • Salius Pharma Pvt. Ltd. - Overview
    • Salius Pharma Pvt. Ltd. - Product / Service
    • Salius Pharma Pvt. Ltd. - Key offerings
    • SWOT
  • 15.15 Sichuan Kelun Pharmaceutical Co. Ltd.
    • Sichuan Kelun Pharmaceutical Co. Ltd. - Overview
    • Sichuan Kelun Pharmaceutical Co. Ltd. - Product / Service
    • Sichuan Kelun Pharmaceutical Co. Ltd. - Key offerings
    • SWOT
  • 15.16 Soxa Formulations and Research Pvt. Ltd.
    • Soxa Formulations and Research Pvt. Ltd. - Overview
    • Soxa Formulations and Research Pvt. Ltd. - Product / Service
    • Soxa Formulations and Research Pvt. Ltd. - Key offerings
    • SWOT
  • 15.17 Terumo Corp.
    • Terumo Corp. - Overview
    • Terumo Corp. - Business segments
    • Terumo Corp. - Key news
    • Terumo Corp. - Key offerings
    • Terumo Corp. - Segment focus
    • SWOT
  • 15.18 Vifor Pharma Management Ltd.
    • Vifor Pharma Management Ltd. - Overview
    • Vifor Pharma Management Ltd. - Product / Service
    • Vifor Pharma Management Ltd. - Key offerings
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations